Skip to content
Loading…
Eli Lilly & Co. plans to buy Merida Biosciences Inc. for as much as $2.88 billion in cash to expand in autoimmune and allergic diseases, part of an effort to build beyond the weight-loss and diabetes markets that made it the largest pharmaceutical company in the world. Lilly has…
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.